Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm

JE Haberer, DR Bangsberg, JM Baeten, K Curran… - Aids, 2015 - journals.lww.com
To date, six clinical trials have explored the efficacy of pre-exposure prophylaxis (PrEP)
against HIV infection using oral tenofovir and/or emtricitabine/tenofovir [1–6]. Efficacy ranged …

Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions

MA Spinelli, JE Haberer, PR Chai… - Current Hiv/Aids …, 2020 - Springer
Abstract Purpose of Review Traditional methods to assess antiretroviral adherence, such as
self-report, pill counts, and pharmacy refill data, may be inaccurate in determining actual pill …

[图书][B] Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

World Health Organization - 2021 - books.google.com
These consolidated guidelines on HIV prevention, testing, treatment, service delivery and
monitoring bring together existing and new clinical and programmatic recommendations …

Use of artificial intelligence in infectious diseases

S Agrebi, A Larbi - Artificial intelligence in precision health, 2020 - Elsevier
Infectious diseases are caused by microorganisms belonging to the class of bacteria,
viruses, fungi, or parasites. These pathogens are transmitted, directly or indirectly, and can …

Improving antiretroviral therapy adherence in resource‐limited settings at scale: a discussion of interventions and recommendations

JE Haberer, L Sabin, KR Amico, C Orrell… - African Journal of …, 2017 - journals.lww.com
Introduction: Successful population-level antiretroviral therapy (ART) adherence will be
necessary to realize both the clinical and prevention benefits of antiretroviral scale-up and …

[HTML][HTML] HIV treatment adherence, drug resistance, virologic failure: evolving concepts

JB Nachega, VC Marconi, GU Van Zyl… - … disorders drug targets, 2011 - ncbi.nlm.nih.gov
Poor adherence to combined antiretroviral therapy (cART) has been shown to be a major
determinant of virologic failure, emergence of drug resistant virus, disease progression …

Five-year outcomes of the China national free antiretroviral treatment program

F Zhang, Z Dou, Y Ma, Y Zhao, Z Liu… - Annals of internal …, 2009 - acpjournals.org
Background: China's National Free Antiretroviral Treatment Program began in 2002 and, by
August 2008, included more than 52 000 patients. Objective: To report 5-year outcomes on …

Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: a nationwide study

J Kim, E Lee, BJ Park, JH Bang, JY Lee - Scientific reports, 2018 - nature.com
For ideal clinical benefit, human immunodeficiency virus (HIV)-infected individuals should
receive continuous medication. This is the first nationwide antiretroviral therapy (ART) …

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

RE Barth, MFS van der Loeff, R Schuurman… - The Lancet infectious …, 2010 - thelancet.com
Following large-scale roll-out of antiretroviral therapy in sub-Saharan Africa, the non-clinical
efficacy of antiretroviral therapy has received little attention. We aimed to systematically …

Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring

JR Castillo-Mancilla, JE Haberer - Current Hiv/aids Reports, 2018 - Springer
Abstract Purpose of Review In this review, we present new developments in antiretroviral
adherence, focusing on pharmacological measures and real-time adherence monitoring. In …